Aesthetic Medical International Holdings (PAIYY) Fair Value & Analysis

Healthcare · US · Market cap $730K

Below-average quality, currently priced close to our fair value.

What matters now

• The price sits above even our optimistic bull case ($0.0197). The favourable scenario is already priced in.
• The price sits close to our fair value, market and models broadly agree here, little valuation tension.
• The models converge in a tight band ($0.0189 to $0.0197), unusually little disagreement for a valuation.
• Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.

How to read this chart

60‑month range $0.0140 – $10.75 · fair‑value band $0.0189 – $0.0197 · the $0.0210 price screens above the $0.0193 fair value. Dashed = 300-day average. As of Jul 31, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Aesthetic Medical International Holdings (PAIYY) currently trades at $0.0210, while our model-based Fair Value estimate is $0.0193, implying the stock looks roughly 8.1% fairly valued today. The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Aesthetic Medical International Holdings generated revenue of $723M at a net margin of -7.4%. Revenue declined 5.1% year over year. Net debt stands at $215M. Fundamentals as of Jul 31, 2026

Our scenario range runs from $0.0189 (bear case) to $0.0197 (bull case); at $0.0210, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -8%, PAIYY screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Multiples ($0.0193) versus Earnings-Based ($0.0100). Highest evidence: ROIC Compounder (72).

Key figures & financial health

Quality Score breakdown

About the company

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China.

Full company description

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye lid surgery, rhinoplasty, breast augmentation, liposuction, facelifts; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Aesthetic Medical International Holdings reported revenue of $703M in FY2025 versus $646M in FY2021, a compound +2.2%/yr. Reported net income was −$51.9M in FY2025.

Watch PAIYY: get an alert when its fair value changes →

Peer Group

Medical Care Facilities · 261 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.